Envista Holdings Corp (NVST)

Return on total capital

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands -1,038,100 -1,285,300 -1,255,000 -15,700 8,500 299,800 321,400 303,500 327,400 328,200 350,000 376,600 385,600 384,000 363,200 160,700 30,500 10,700
Long-term debt US$ in thousands 1,278,300 1,305,600 1,388,700 1,390,500 1,398,100 1,381,000 875,600 873,800 870,700 851,600 864,100 876,900 883,400 887,800 893,200 892,200 907,700 1,755,500
Total stockholders’ equity US$ in thousands 2,934,800 3,072,500 2,976,700 4,140,300 4,173,900 4,293,200 4,311,000 4,279,000 4,206,900 3,957,900 4,016,000 4,030,900 4,057,600 3,946,700 3,868,500 3,746,900 3,720,600 3,557,600
Return on total capital -24.64% -29.36% -28.75% -0.28% 0.15% 5.28% 6.20% 5.89% 6.45% 6.82% 7.17% 7.67% 7.80% 7.94% 7.63% 3.46% 0.66% 0.20%

December 31, 2024 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $-1,038,100K ÷ ($1,278,300K + $2,934,800K)
= -24.64%

Envista Holdings Corp's return on total capital has shown fluctuating trends over the period from September 30, 2020, to December 31, 2024. The ratio started at a low of 0.20% in September 2020, gradually increased, and peaked at 7.94% in September 2021. However, from March 2022 onwards, the return on total capital began to decline steadily, reaching negative values by June 2024. The significant drop in the ratio from June 30 to December 31, 2024, suggests a substantial decrease in the company's profitability relative to its total capital employed. This negative trend may indicate challenges in generating returns on investments and managing capital effectively during this period.


Peer comparison

Dec 31, 2024

Company name
Symbol
Return on total capital
Envista Holdings Corp
NVST
-24.64%
Dentsply Sirona Inc
XRAY
-9.37%